This protocol is judged by an institutional assessment board, an unbiased group that opinions any scientific trials involving human beings. If a research entails a Schedule I drug, once the board approves the protocol as ethical, the scientists must apply for an investigational new drug (IND) range within the FDA.Nice trippy buzz plus a comfortable